Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Genomma Lab has announced the Mexican Federal COFEPRIS has granted the Sanitary License which permits the Company's new manufacturing facility to begin operations.
read more
As drug manufacturing has globalized, ensuring that companies meet the FDA strict standards for producing safe, effective and high-quality medicines has become increasingly challenging.
read more
Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules.
read more
Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus.
read more
Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third ADC produced at the site.
read more
Starting in July, the commercial brand for Eurofins Alphora will be Eurofins CDMO, falling under the CDMO umbrella in conjunction with Eurofins Amatsigroup.
read more
Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
read more
Samsung BioLogics and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy.
read more
The FDA and the EMA are publishing the discussion and main conclusions from a workshop held on November 26, 2018, at the EMA headquarters in London.
read more
Wednesday, August 07, 2019
Cambrex has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.
read more
Thursday, August 08, 2019
Purdue has sold its Treyburn, North Carolina, plant to Novo Nordisk for an undisclosed sum, according to an announcement Purdue CEO Craig Landau sent to the plant’s employees.
read more
Thursday, August 08, 2019
Sartorius Stedim Biotech (SSB) announced the launch of new services for mammalian cell bank manufacture under GMP conditions.
read more
HALIX announced they have met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility in Leiden Bio Science Park.
read more
Blue Water Vaccines has signed an agreement with Ology Bioservices to manufacture a novel universal influenza vaccine.
read more
Eurofins Genomics has completed the acquisition of Blue Heron Biotech, a company specializing in advanced gene synthesis.
read more